CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Total revenues (Note 3)	$ 1,381	$ 1,240
Total cost of revenues	1,262	1,034
Gross profit	119	206
Operating expenses
Research and development	458	381
Selling, general, and administrative	542	480
Total operating expenses	1,000	861
Loss from operations	(881)	(655)
Interest income	50	81
Interest expense (Note 8)	(65)	(72)
Other income, net	478	107
Loss before income taxes	(418)	(539)
Provision for income taxes	2	(2)
Net loss	(416)	(541)
Less: Net income attributable to noncontrolling interest	0	4
Net loss attributable to common stockholders	(416)	(545)
Net loss attributable to common stockholders, basic	(416)	(545)
Net loss attributable to common stockholders, diluted	$ (416)	$ (545)
Net loss per share attributable to Class A and Class B common stockholders, basic (in dollars per share)	$ (0.33)	$ (0.48)
Net loss per share attributable to Class A and Class B common stockholders, diluted (in dollars per share)	$ (0.33)	$ (0.48)
Weighted-average common shares outstanding, basic (in shares)	1,249	1,137
Weighted-average common shares outstanding, diluted (in shares)	1,249	1,137
Automotive
Total revenues (Note 3)	$ 908	$ 922
Total cost of revenues	970	830
Software and services
Total revenues (Note 3)	473	318
Total cost of revenues	$ 292	$ 204

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities:
Net loss	$ (416)	$ (541)
Depreciation and amortization	194	200
Stock-based compensation expense	207	188
Gain on strategic investments	(506)	(101)
Other non-cash activities	74	20
Changes in operating assets and liabilities:
Accounts receivable, net	211	31
Inventory	(80)	(364)
Other assets	89	14
Accounts payable and accrued liabilities	(182)	334
Deferred revenues	(290)	59
Other liabilities	(4)	(28)
Net cash used in operating activities	(703)	(188)
Cash flows from investing activities:
Purchases of equity securities and short-term investments	(558)	(835)
Sales of equity securities and short-term investments	16	48
Maturities of short-term investments	1,003	717
Deconsolidation of Mind Robotics, Inc.	(114)	0
Capital expenditures	(372)	(338)
Net cash used in investing activities	(25)	(408)
Cash flows from financing activities:
Proceeds from stock-based compensation programs	1	2
Other financing activities	(3)	(8)
Net cash used in financing activities	(2)	(6)
Effect of exchange rate changes on cash and cash equivalents	(4)	1
Net change in cash	(734)	(601)
Cash, cash equivalents, and restricted cash—Beginning of period	3,579	5,294
Cash, cash equivalents, and restricted cash—End of period	2,845	4,693
Supplemental disclosure of non-cash investing and financing activities:
Capital expenditures included in liabilities	534	423
Capital stock issued to settle bonuses	110	47
Right-of-use assets obtained in exchange for operating lease liabilities	$ 60	$ 73

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Mar. 31, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents (Note 5)	$ 2,845	$ 3,579
Short-term investments (Note 5)	1,985	2,503
Accounts receivable, net	342	555
Inventory (Note 6)	1,543	1,594
Other current assets	330	361
Total current assets	7,045	8,592
Property, plant, and equipment, net (Note 7)	5,434	5,119
Operating lease assets, net	601	571
Strategic investments (Note 2)	669	119
Other non-current assets	484	463
Total assets	14,233	14,864
Current liabilities:
Accounts payable	754	595
Accrued liabilities (Note 9)	1,045	1,438
Current portion of deferred revenues, lease liabilities, and other liabilities	1,554	1,660
Total current liabilities	3,353	3,693
Long-term debt (Note 8)	4,442	4,440
Non-current lease liabilities	580	551
Other non-current liabilities	1,429	1,586
Total liabilities	9,804	10,270
Commitments and contingencies (Note 13)
Stockholders' equity:
Preferred stock, $0.001 par value; 10 shares authorized and 0 shares issued and outstanding as of December 31, 2025 and March 31, 2026	0	0
Common stock, $0.001 par value; 5,258 and 5,258 shares authorized and 1,240 and 1,260 shares issued and outstanding as of December 31, 2025 and March 31, 2026, respectively (Note 14)	1	1
Additional paid-in capital	31,767	31,508
Accumulated deficit	(27,367)	(26,951)
Accumulated other comprehensive income	2	8
Noncontrolling interest	26	28
Total stockholders' equity	4,429	4,594
Total liabilities and stockholders' equity	$ 14,233	$ 14,864